ÂÜÀòÂÒÂ×

Carl Gibbons has extensive experience in market access, pricing, and health economics. Carl currently holds the position of Director, Market Access & Reimbursement at ADVANZ PHARMA since September 2023. Prior to that, they were the Director, Market Access and Reimbursement, UK & Ireland at ADVANZ PHARMA from September 2019 to September 2023. Before joining ADVANZ PHARMA, they worked as the Head of Pricing and Market Access, Northern Europe at Camurus from September 2017 to September 2019. From January 2017 to September 2017, they served as the Global Head of HTA, Biodermatology at LEO Pharma. Carl also held the position of Head of Market Access, Region EU+ at LEO Pharma from July 2013 to January 2017. In 2011, Carl worked at Roche Pharmaceuticals as the Group Health Economics Manager UK, where they were responsible for managing a team of health economists and overseeing non-cancer drugs, including pre-launch activities. From September 2009 to June 2011, they worked as the Market Access Manager UK at Celgene, focusing on HTA and market access of oncology products. Carl started their career at Schering-Plough, holding roles as a Health Economist and Research Analyst, where they contributed to HTA submissions and conducted statistical analyses to support market access activities. Carl also has experience as a Research Fellow at the London School of Hygiene and Tropical Medicine and as a Lecturer and Data Manager at Deakin University, where they developed teaching units, lectured, and provided statistical and epidemiological expertise.

Carl Gibbons has a Bachelor of Science (BSc) degree in Psychology and a Graduate Diploma in Psychology from the University of Melbourne, where they studied from 1993 to 1997. Carl later pursued a Master of Science (MSc) degree in Public Health, specializing in Health Economics, from the London School of Hygiene and Tropical Medicine, University of London, studying from 2008 to 2010.